Literature DB >> 26968588

Mothers' attitudes in Japan regarding cervical cancer screening correlates with intention to recommend cervical cancer screening for daughters.

Tomomi Egawa-Takata1,2, Yutaka Ueda3,4, Yusuke Tanaka1,2, Akiko Morimoto1,2, Satoshi Kubota1,2, Asami Yagi2, Yoshito Terai1,5, Masahide Ohmichi1,5, Tomoyuki Ichimura1,6, Toshiyuki Sumi1,6, Hiromi Murata1,7, Hidetaka Okada1,7, Hidekatsu Nakai1,8, Masaki Mandai1,8, Kiyoshi Yoshino1,2, Tadashi Kimura1,2, Junko Saito1, Risa Kudo9, Masayuki Sekine9, Takayuki Enomoto1,9, Yorihiko Horikoshi1, Tetsu Takagi1, Kentaro Shimura1.   

Abstract

BACKGROUND: Cervical cancer and its precancerous lesions caused by human papilloma virus (HPV) are steadily increasing in women in Japan. In comparison with women in other resource-rich countries, young women in Japan have a dismally low screening rate for cervical cancer. Our preliminary research has shown that 20-year-old women in Japan usually ask their mothers for advice regarding their initial cervical cancer screening. The objective of our current research is to determine the social factors among mothers in Japan that are causing them to give advice to their daughters regarding the HPV vaccine and cervical cancer screening.
METHODS: The survey's targets were mothers who had 20-year-old daughters. We recruited respondents from the roster of a commercial internet survey panel. We analyzed for correlations between a mother's knowledge concerning cervical cancer, her recent cancer screening history, and the advice she gave to her daughter regarding cervical cancer screening.
RESULTS: We obtained 618 valid answers to the survey. Compared with mothers who did not get screening, mothers who had cervical cancer screening had significantly more knowledge about cervical cancer and its screening (p < 0.05). The daughters of mothers with recent screening had received HPV vaccination more often than those of mothers without recent screening (p = 0.018). Mothers with recent screening histories tended more often to encourage their daughters to have cervical cancer screening (p < 0.05). When mothers were properly educated concerning cervical cancer and its screening, they were significantly more likely than before to recommend that their daughters have it (p < 0.0001).
CONCLUSIONS: In young Japanese women, given the important role their mothers have in their lives, it is probable that we could improve their cervical cancer screening rate significantly by giving their mothers better medical information, and a chance to experience cervical cancer screening for themselves.

Entities:  

Keywords:  Attitude; Cervical cancer screening; Daughter; Fact sheet; HPV vaccine; Japan; Mother; Questionnaire

Mesh:

Substances:

Year:  2016        PMID: 26968588     DOI: 10.1007/s10147-016-0970-4

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  13 in total

1.  Do we need a different strategy for HPV screening and vaccination in East Asia?

Authors:  Shiho Miura; Koji Matsumoto; Akinori Oki; Toyomi Satoh; Hajime Tsunoda; Toshiharu Yasugi; Yuji Taketani; Hiroyuki Yoshikawa
Journal:  Int J Cancer       Date:  2006-12-01       Impact factor: 7.396

2.  Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication.

Authors:  Ni Li; Silvia Franceschi; Rebecca Howell-Jones; Peter J F Snijders; Gary M Clifford
Journal:  Int J Cancer       Date:  2011-02-15       Impact factor: 7.396

3.  The bumpy road to socialise nature: sex education in Japan.

Authors:  Huiyan Fu
Journal:  Cult Health Sex       Date:  2011-06-30

4.  HPV vaccination crisis in Japan.

Authors:  Sharon J B Hanley; Eiji Yoshioka; Yoshiya Ito; Reiko Kishi
Journal:  Lancet       Date:  2015-06-27       Impact factor: 79.321

5.  Japan's failure to vaccinate girls against human papillomavirus.

Authors:  Yutaka Ueda; Takayuki Enomoto; Masayuki Sekine; Tomomi Egawa-Takata; Akiko Morimoto; Tadashi Kimura
Journal:  Am J Obstet Gynecol       Date:  2014-11-27       Impact factor: 8.661

6.  Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update.

Authors:  Jennifer S Smith; Lisa Lindsay; Brooke Hoots; Jessica Keys; Silvia Franceschi; Rachel Winer; Gary M Clifford
Journal:  Int J Cancer       Date:  2007-08-01       Impact factor: 7.396

7.  Association between maternal preventive care utilization and adolescent vaccination: it's not just about Pap testing.

Authors:  Amanda R Markovitz; Ji Young Song; Michael L Paustian; Darline K El Reda
Journal:  J Pediatr Adolesc Gynecol       Date:  2013-12-04       Impact factor: 1.814

8.  Global cancer statistics.

Authors:  Ahmedin Jemal; Freddie Bray; Melissa M Center; Jacques Ferlay; Elizabeth Ward; David Forman
Journal:  CA Cancer J Clin       Date:  2011-02-04       Impact factor: 508.702

9.  Against which human papillomavirus types shall we vaccinate and screen? The international perspective.

Authors:  Nubia Muñoz; F Xavier Bosch; Xavier Castellsagué; Mireia Díaz; Silvia de Sanjose; Doudja Hammouda; Keerti V Shah; Chris J L M Meijer
Journal:  Int J Cancer       Date:  2004-08-20       Impact factor: 7.396

10.  Papanicolaou screening behavior in mothers and human papillomavirus vaccine uptake in adolescent girls.

Authors:  Chun Chao; Jeff M Slezak; Karen J Coleman; Steven J Jacobsen
Journal:  Am J Public Health       Date:  2009-04-16       Impact factor: 9.308

View more
  3 in total

1.  Motivating Mothers to Recommend Their 20-Year-Old Daughters Receive Cervical Cancer Screening: A Randomized Study.

Authors:  Tomomi Egawa-Takata; Yutaka Ueda; Akiko Morimoto; Yusuke Tanaka; Asami Yagi; Yoshito Terai; Masahide Ohmichi; Tomoyuki Ichimura; Toshiyuki Sumi; Hiromi Murata; Hidetaka Okada; Hidekatsu Nakai; Masaki Mandai; Shinya Matsuzaki; Eiji Kobayashi; Kiyoshi Yoshino; Tadashi Kimura; Junko Saito; Yumiko Hori; Eiichi Morii; Tomio Nakayama; Mikiko Asai-Sato; Etsuko Miyagi; Masayuki Sekine; Takayuki Enomoto; Yorihiko Horikoshi; Tetsu Takagi; Kentaro Shimura
Journal:  J Epidemiol       Date:  2017-11-11       Impact factor: 3.211

2.  A single-arm study evaluating bevacizumab, cisplatin, and paclitaxel followed by single-agent bevacizumab in Japanese patients with advanced cervical cancer.

Authors:  Toru Sugiyama; Mika Mizuno; Yoichi Aoki; Manabu Sakurai; Tadaaki Nishikawa; Eisuke Ueda; Kosei Tajima; Nobuhiro Takeshima
Journal:  Jpn J Clin Oncol       Date:  2016-10-07       Impact factor: 3.019

3.  A survey of 20-year-old Japanese women: how is their intention to undergo cervical cancer screening associated with their childhood HPV vaccination status?

Authors:  Reisa Kakubari; Tomomi Egawa-Takata; Yutaka Ueda; Yusuke Tanaka; Asami Yagi; Akiko Morimoto; Yoshito Terai; Masahide Ohmichi; Tomoyuki Ichimura; Toshiyuki Sumi; Hiromi Murata; Hidetaka Okada; Hidekatsu Nakai; Noriomi Matsumura; Kiyoshi Yoshino; Tadashi Kimura; Junko Saito; Risa Kudo; Masayuki Sekine; Takayuki Enomoto; Yorihiko Horikoshi; Tetsu Takagi; Kentaro Shimura
Journal:  Hum Vaccin Immunother       Date:  2020-07-30       Impact factor: 3.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.